 |
PDBsum entry 4zuu
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
4zuu
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Immunol
196:1943-1954
(2016)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural Illumination of Equine MHC Class I Molecules Highlights Unconventional Epitope Presentation Manner That Is Evolved in Equine Leukocyte Antigen Alleles.
|
|
S.Yao,
J.Liu,
J.Qi,
R.Chen,
N.Zhang,
Y.Liu,
J.Wang,
Y.Wu,
G.F.Gao,
C.Xia.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
MHC class I (MHC I)-restricted virus-specific CTLs are implicated as critical
components in the control of this naturally occurring lentivirus and in the
protective immune response to the successfully applied attenuated equine
infectious anemia virus vaccine in the horse. Nevertheless, the structural basis
for how the equine MHC I presents epitope peptides remains unknown. In this
study, we investigated the binding of several equine infectious anemia
virus-derived epitope peptides by the ability to refold recombinant molecules
and by thermal stability, and then by determining the x-ray structure of five
peptide-MHC I complexes: equine MHC class I allele (Eqca)-N*00602/Env-RW12,
Eqca-N*00602/Gag-GW12, Eqca-N*00602/Rev-QW11, Eqca-N*00602/Gag-CF9, and
Eqca-N*00601/Gag-GW12. Although Eqca-N*00601 and Eqca-N*00602 differ by a single
amino acid, Eqca-N*00601 exhibited a drastically different peptide presentation
when binding a similar CTL epitope, Gag-GW12; the result makes the previously
reported function clear to be non-cross-recognition between these two alleles.
The structures plus Eqca-N*00602 complexed with a 9-mer peptide are particularly
noteworthy in that we illuminated differences in apparent flexibility in the
center of the epitope peptides for the complexes with Gag-GW12 as compared with
Env-RW12, and a strict selection of epitope peptides with normal length. The
featured preferences and unconventional presentations of long peptides by equine
MHC I molecules provide structural bases to explain the exceptional
anti-lentivirus immunity in the horse. We think that the beneficial reference
points could serve as an initial platform for other human or animal lentiviruses.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
|